Competitiveness and innovation: why France is struggling to hold its own
France is losing ground in Europe in terms of competitiveness and ability to innovate in the health industries. A cumbersome ...
Read moreFrance is losing ground in Europe in terms of competitiveness and ability to innovate in the health industries. A cumbersome ...
Read moreIs the price of innovative drugs an obstacle to ensuring that each patient receives the best care? The point on ...
Read moreIn the aftermath of the health crisis, Doctor Jean-François Lemoine receives in his series "The Day After" the personalities who ...
Read moreTo allow everyone access to innovative medicines, the pharmaceutical industry union wishes to relaunch the dialogue with all the players ...
Read moreThe exorbitant price of the only drug capable of treating people with spinal muscular atrophy, a rare and fatal genetic ...
Read moreIn a white paper published on Tuesday, June 20, 8 associations for the defense of patients and professionals denounce the ...
Read moreThe Sages of rue Cambon believe that better control of health spending requires, in particular, stricter negotiation of drug prices. ...
Read moreThe treatments would be much less expensive to develop than what the laboratories say. The selling prices would thus be ...
Read moreCanadians spend on average more than the French or the Germans on health care. The lack of universal coverage partly ...
Read moreThe Economic, Social and Environmental Council calls for strong measures to lower the price of innovative drugs.Innovative drugs represent the ...
Read moreOne in five innovative drugs could be rationed in England, where the health system is going through a deep financial ...
Read moreA treatment for hepatitis C has been renegotiated downward. Sold under the name Zepatier, it will be available at a ...
Read moreMAINTENANCE - The legislator has taken several measures to reduce the costs associated with drugs without penalizing innovation.We now know ...
Read moreThe price of the emergency treatment for anaphylactic shock, EpiPen, had been increased to $ 600. The industrialist has just ...
Read moreSofosbuvir has just seen its patent partially canceled, which should allow the price of this treatment to be renegotiated, which ...
Read moreAlmost half of pharmacists do not respect their obligations regarding the display of drug prices. This is what a recent ...
Read moreVaccination against papillomaviruses is still too rare in the world. However, it reduces precancerous lesions. Reducing the cost of doses ...
Read moreAce Mind website (acemind.net) provides you with the latest and accurate medical news, healthcare guides, technology news, technical tutorials, automobiles news, and instructions and knowledge about other fields.
Contact us: khaobanmuang@gmail.com